At DDW 2025, researchers presented their findings on the effects of MAFLD on outcomes of patients with hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related deaths worldwide due to lack of effective diagnosis at early stages and limited comprehension of its pathogenesis, thus ...

A dad diagnosed with a rare form of liver cancer was just given three months left to live – after putting down “warning sign” ...

Abstract: The breast cancer histology image classification task is to classify images into four categories of normal, benign, in situ carcinoma, and invasive carcinoma. A common challenge of the ...

The therapy claims to be the first therapeutic agent to utilise molecularly defined biomarkers for precision-targeted HCC ...